Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AFFIRM: TNX-102 SL in Fibromyalgia
NCT02436096Phase 3Completed
- Sponsor
- Tonix Pharmaceuticals
- Start
- Apr 2015
- Primary completion
- Sep 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of Tonmya in fibromyalgia (FM), sponsored by Tonix Pharmaceuticals. Started Apr 2015; status: completed.
02
Drugs
Tonmya
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT02436096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02436096.